ASH 2018 | Studying the genetics of CLL to prevent Richter’s transformation
VJHemOnc is committed to improving our service to you
Thanks for your feedback, this will help us improve our content for you!
Stephan Stilgenbauer, MD, of the University of Ulm, Ulm, Germany, speaks at the American Society of Hematology (ASH) 2018 Annual Meeting and Exposition in San Diego, CA. He discusses how the genetics of chronic lymphocytic leukemia (CLL) impacts outcome in patients, with particular reference to IGHV, TP53 and MYC mutations. He talks about strategies to prevent Richter’s transformation using existing and novel treatments.
Get great new content delivered to your inboxSign up